| Literature DB >> 27681250 |
Shuyuan Liu1, Zhi Yu1, Hongkai Zhu1, Wei Zhang2, Yuqiong Chen3.
Abstract
BACKGROUND: Natural products have being used as potential inhibitors against carbohydrate-hydrolyzing enzymes to treat diabetes mellitus. Chinese dark tea has various interesting bioactivities. In this study, the active compounds from Qingzhuan dark tea were separated and their anti-diabetic activity was examined using an in vitro enzymatic model.Entities:
Keywords: Anti-diabetes; Camellia sinensis; Dark tea; Tea extracts; α-Glucosidase
Year: 2016 PMID: 27681250 PMCID: PMC5041284 DOI: 10.1186/s12906-016-1361-0
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
Inhibitory effects of Qingzhuan tea fractions on α-glucosidase
| Extracts | IC50 (mg/mL) | Regression equation |
|
|---|---|---|---|
| The crude water extract | 2.47 ± 0.30 * | y = 0.120 × + 0.204 | 0.975 |
| Chloroform fraction | No activity | ||
| Ethyl acetate fraction | 2.27 ± 0.03 * | y = 2.131 × − 0.057 | 0.984 |
|
| 2.94 ± 0.44 * | y = 0.171 × − 0.002 | 0.991 |
| Sediment fraction | 3.02 ± 0.07 * | y = 0.042 × + 0.373 | 0.991 |
| Residual aqua fraction | 5.24 ± 0.11 | y = 0.101 × − 0.029 | 0.987 |
| Acarbose | 4.64 ± 0.57 | y = 0.045 × + 0.291 | 0.987 |
Note: n=3, Mean ± SD
* p > 0.01 when compared to acarbose
The main constituent of Qingzhuan tea extracts (%)
| Extracts | Polyphenol | Carbohydrate | Caffeine | Theaflavin | Thearubigin | Theabrownin |
|---|---|---|---|---|---|---|
| The crude water extract | 18.25 ± 0.21 cC | 14.74 ± 1.02 bA | 5.82 ± 0.06 bB | 0.15 ± 0.01 cC | 5.51 ± 0.14 bB | 21.17 ± 0.21 bcC |
| Chloroform fraction | 0.98 ± 0.06 fF | 1.28 ± 0.33 dC | 70.55 ± 0.01 aA | 0.62 ± 0.00 bB | 0.74 ± 0.00 cC | 0.21 ± 0.00 eE |
| Ethyl acetate fraction | 62.72 ± 2.63 aA | 5.85 ± 1.16 cB | 0.50 ± 0.01 cC | 1.70 ± 0.23 aA | 24.21 ± 3.18 aA | 4.17 ± 0.17 dD |
|
| 31.09 ± 0.73 bB | 15.56 ± 0.07 abA | 0.30 ± 0.002 dD | 0.24 ± 0.03 cC | 28.00 ± 1.68 aA | 24.82 ± 1.25 abB |
| Sediment fraction | 9.16 ± 0.35 eE | 16.65 ± 0.04 aA | ND | 0.02 ± 0.01 dD | ND | 27.18 ± 0.80 aA |
| Residual aqua fraction | 11.15 ± 0.31 dD | 17.19 ± 0.20 aA | 0.13 ± 0.02 eE | 0.03 ± 0.03 dD | 0.14 ± 0.19 cC | 19.56 ± 0.05 cC |
Note: At the same column, different capital letters mean a significant difference at p < 0.01 level and small letters at p < 0.05 level compare to each other, ND means not detected
α-Glucosidase inhibition of various subfractions obtained from the ethyl acetate fraction
| Subfraction | IC50 (mg/ML) | Regression equation |
|
|---|---|---|---|
| QEF1 | 12.31 ± 0.60 ** | y = 0.074 × − 0.411 | 0.986 |
| QEF2 | 7.57 ± 0.54 ** | y = 0.075 × − 0.068 | 0.989 |
| QEF3 | 6.22 ± 0.70 ** | y = 0.076 × + 0.027 | 0.968 |
| QEF4 | 5.39 ± 0.58 | y = 0.079 × + 0.074 | 0.987 |
| QEF5 | 3.33 ± 0.11 * | y = 0.157 × − 0.022 | 0.996 |
| QEF6 | 1.61 ± 0.06 ** | y = 0.200 × + 0.178 | 0.973 |
| QEF7 | 0.95 ± 0.05** | y = 0.391 × + 0.128 | 0.961 |
| QEF8 | 0.066 ± 0.01** | y = 4.640 × + 0.193 | 0.968 |
| Acarbose | 4.64 ± 0.57 | y = 0.045 × + 0.291 | 0.987 |
Note: n = 3, Mean ± SD
* p < 0.05, ** p < 0.01 when compared to acarbose
Fig. 1Lineweaver-Burk plot of QEF8 towards the substrate pNPG at different concentrations
K and V values of α-glucosidase in the presence of different concentration of QEF8
| Concentration of QEF8 (mg/mL) |
|
|
|
|---|---|---|---|
| 0.00 | 0.81 ± 0.01 d | 0.23 ± 0.005 a | 77.10 |
| 0.02 | 1.54 ± 0.05 c | 0.23 ± 0.007 a | |
| 0.06 | 2.00 ± 0.08 b | 0.220 ± 0.003 a | |
| 0.10 | 2.64 ± 0.10 a | 0.23 ± 0.006 a |
Note: At the same column, different small letters mean a significant difference at p < 0.05 level compared to each other
Fig. 2HPLC chromatogram of individual phenolic compounds in the QEF8. peak 1 GA: [M + H]+ 171.0, MS2 152.8, 126.9; peak 2 EGC: [M + H]+ 307.1, MS2 288.9, 138.9; peak 3 C: [M + H]+ 291.0, MS2 273.4, 139.4; peak 4 EGCG: [M + H]+ 459.2, MS2 288.9, 138.9; peak 5 GCG: [M + H]+ 459.2, MS2 288.9, 138.9; peak 6 EC: [M + H]+ 291.0, MS2 273.4, 139.4; peak 7 ECG: [M + H]+ 443.1, MS2 272.9, 150.9; and peak 8 CG: [M + H]+ 443.1, MS2 272.9, 150.9
Summary of data used to quantify major components of QEF8 by HPLC method
| Compound | Regression equation |
| Linear range (μg/mL) | LOD (μg/mL) | Content (%) |
|---|---|---|---|---|---|
| GA | y = 12.285 × − 8.215 | 0.9997 | 3.91–31.25 | 0.76 | 0.60 ± 0.03 |
| EGC | y = 1.112 × − 8.101 | 0.9998 | 54.69–437.50 | 9.59 | 0.55 ± 0.23 |
| C | y = 2.214 × − 2.175 | 0.9998 | 9.38–75.00 | 1.34 | 1.29 ± 0.15 |
| EGCG | y = 7.721 × − 107.250 | 0.9989 | 62.50–500.00 | 24.05 | 30.94 ± 0.45 |
| GCG | y = 1.530 × − 4.051 | 0.9999 | 25.00–200.00 | 3.42 | 2.74 ± 0.20 |
| EC | y = 20.066 × − 33.854 | 0.9987 | 9.38–75.00 | 3.84 | 1.18 ± 0.02 |
| ECG | y = 9.056 × − 30.433 | 0.9995 | 18.75–150.00 | 4.9 | 10.61 ± 0.15 |
| CG | y = 8.725 × − 8.939 | 0.9993 | 4.69–37.50 | 1.40 | 0.53 ± 0.04 |
Note: LOD (limit of detection) was defined as the value equal to a signal-to-noise ratio of three
Fig. 3Inhibitory effects of ECG on α-glucosidase
Fig. 4Inhibitory effects of EGCG on α-glucosidase